Cart summary

You have no items in your shopping cart.

YK-4-279

SKU: orb1222912

Description

YK-4-279 is a ETV1 inhibitor, which inhibitor protein-protein interactions between ES-FLI1 and RHA.YK-4-279 effectively antagonizes EWS-FLI1 induced leukemia in a transgenic mouse model. YK-4-279 demonstrates specificity in targeting the oncogene EWS-FLI1. YK-4-279, prevents prostate cancer growth and metastasis in a mouse xenograft model.(In Vitro):YK-4-279 (3-30 μM; overight) dissociates EWS-FLI1 from RHA in Ewing’s sarcoma family tumor (ESFT) cells.YK-4-279 (3-30 μM; 14 h) nearly eliminates cyclin D1 in TC32 cells.YK-4-279 (3-30 μM; 72 h) potently and specifically inhibits ESFTs.YK-4-279 (50 μM; 6 h) induces substantial apoptosis of ESFT cells.YK-4-279 (0.1-30 μM; 72 h) inhibits the growth of ESFT, prostate, breast and pancreatic cancer cells.(In Vivo):YK-4-279 (1.5 mg; i.p. once) inhibited ESFT tumor growth.

Images & Validation

Key Properties

CAS Number1037184-44-3
MW366.2
Purity>98% (HPLC)
FormulaC17H13Cl2NO4
SMILESCOC1=CC=C(C=C1)C(=O)CC1(O)C(=O)NC2=C(Cl)C=CC(Cl)=C12
TargetRNA helicase A
SolubilityDMSO : 25 mg/mL. 68.27 mM;

Bioactivity

In Vivo
Animal model: Beige mice with orthotopic ESFT and ESFT xenografts. Dosage: 1.5 mg. Administration: Intraperitoneal injection; 1.5 mg once. Result: Effectively redeced tumor volume of CHP100 and ESFT xenografts (TC71 and CHP100).
In Vitro
Cell Viability Assay Cell line: TC32, ES925, GUES1, TC71, A673, A4573, CHP100, PANC1, ASP1, MCF-7, MDA-MB-231, PC-3, HFK and HEC cell lines. Concentration: 3-30 μM. Incubation time: 72 h. Result: Inhibited cell growth with IC50s of 900 nM, 1 μM and 8 μM for TC32, ES925 and GUES1 cells, respectively. Apoptosis Analysis Cell line: TC32, HEK, HEC and HFK cell lines. Concentration: 50 μM. Incubation time: 6 h. Result: Induced apoptosis of ESFT cells and increased caspase-3 activity. Cell Viability Assay Cell line: TC32, TC71, RDES, SKES, MMH-ES-1, STA-ET 7.2, A4573, PC3, MCF7, MDA-MB-231, PANC1 and ASPC1 cell lines Concentration: 0.1-30 μM Incubation time: 72 h. Result: Inhibited cell growth with IC50s of 0.94, 1.83, 1.03, 0.33, 0.94, 0.60, 1.46, 4.95, 22.82, 0.82, 1.514 and 14.28 μM for TC32, TC71, RDES, SKES, MMH-ES-1, STA-ET 7.2, A4573, PC3, MCF7, MDA-MB-231, PANC1 and ASPC1 cells, respectively.

Storage & Handling

StorageStorage temperature: -20°C. Stability: ≥ 2 years
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

YK-4-279 | YK4-279 | YK 4-279 | YK 4279

Similar Products

  • YK-4-279 [orb1305822]

    99.89%

    1037184-44-3

    366.2

    C17H13Cl2NO4

    25 mg, 50 mg, 1 ml x 10 mM (in DMSO), 5 mg, 10 mg, 100 mg, 200 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

YK-4-279 (orb1222912)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

500 mg
5 mg
$ 100.00
10 mg
$ 120.00
25 mg
$ 200.00
50 mg
$ 350.00
100 mg
$ 600.00
200 mg
$ 900.00